PlainPharmaWatch

CMS Open Payments · Tool

Carbofix Spine Inc vs MIS Implants Technologies, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Carbofix Spine Inc has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 3,217, versus 2,592 for the other company. Its single largest recorded recipient represents 51.0% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Carbofix Spine Inc
HHI 3,217 · top recipient 51.0%
Ranked #543 of 1,838 companies by HHI
MIS Implants Technologies, Inc.
HHI 2,592 · top recipient 32.2%
Ranked #633 of 1,838 companies by HHI

Payment Overview

Company A

Carbofix Spine Inc

Total Payments
$62.5K
% of Industry
0.0%
Transactions
87
Avg per Transaction
$718.31
Recipients
83
Avg per Recipient
$752.93
Payment Types
2
Top Payment Type
Consulting Fee
Total Payments
$62.9K
% of Industry
0.0%
Transactions
12
Avg per Transaction
$5.2K
Recipients
11
Avg per Recipient
$5.7K
Payment Types
2
Top Payment Type
Compensation for Faculty or Speaker (Medical Education)

Highlighted values indicate the higher figure for each metric.

Total payments compared

Carbofix Spine Inc vs MIS Implants Technologies, Inc. - total reported payments in CMS Open Payments PY2024

MIS Implants Technologies,…$62.9KCarbofix Spine Inc$62.5K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Carbofix Spine Inc

Consulting Fee $46.7K

89.9%

Food and Beverage $5.2K

10.1%

MIS Implants Technologies, Inc.

Compensation for Faculty or Speaker (Medical Education) $43.6K

77.3%

Travel and Lodging $12.8K

22.7%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Carbofix Spine Inc

  1. 1

    JOHN J KRESL

    $26,520.87 · 4 txns

  2. 2

    SAMAN SHABANI

    $9,500.00 · 2 txns

  3. 3

    SCOT D MILLER

    $8,172.63 · 1 txns

  4. 4

    ISADOR H LIEBERMAN

    $2,833.21 · 5 txns

  5. 5

    SHALIN SHREYASKUMAR PATEL

    $297.45 · 4 txns

MIS Implants Technologies, Inc.

  1. 1

    ARIEL RAIGRODSKI

    $18,178.00 · 4 txns

  2. 2

    WAEL ATT

    $17,106.00 · 2 txns

  3. 3

    TARA LYN AGHALOO

    $12,247.00 · 3 txns

  4. 4

    LUCIANO RETANA

    $6,850.00 · 1 txns

  5. 5

    KYLE STANLEY

    $2,000.00 · 1 txns

Summary Comparison

Metric Carbofix Spine Inc MIS Implants Technologies, Inc.
Total Payments $62.5K $62.9K
% of Industry Total 0.0% 0.0%
Transaction Count 87 12
Avg per Transaction $718.31 $5.2K
Recipient Count 83 11
Avg per Recipient $752.93 $5.7K
Payment Type Count 2 2
Top Payment Type Consulting Fee Compensation for Faculty or Speaker (Medical Education)

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.